# Crick-UCLH-Legacy-VOCs-2021-05

**Data from AstraZeneca and Pfizer available here: https://github.com/davidlvb/Crick-UCLH-Legacy-AZ-VOCs-2021-06**

Data and analysis scripts for Wall, Wu _et al._, _Lancet_, 2021.

"Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination"

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01290-3/fulltext

Please cite:

Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Nicod J, Goldstone R, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DLV. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021 Jun 19;397(10292):2331-2333. doi: 10.1016/S0140-6736(21)01290-3. Epub 2021 Jun 3. PMID: 34090624; PMCID: PMC8175044.

Available in this repository:
 * Crick_Legacy_2021-24-05_B-1-617-2_PUBLIC.Rda
 * Crick_Legacy_2021-24-05_B-1-617-2_GeneratePlots.R
